The percentage of peripheral CD8+ T cells expressing mCD127 was elevated in patients with primary cutaneous melanoma (81.32 ± 7.68%) when compared with healthy controls (67.05 ± 9.72%; P < 0.0001, Fig. 1b). The gene discussed is CD8A; the disease is cutaneous melanoma.